Ligand-protein docking studies of potential HIV-1 drug compounds using the algorithm FlexX

Area of Science:

• Biochemistry
• Structural Biology
• Drug Discovery

Background:

• The Vpu protein of Human Immunodeficiency Virus type 1 (HIV-1) plays a crucial role in viral pathogenesis.
• Its transmembrane domain is a potential target for antiviral drug development.

Purpose of the Study:

• To identify potential drug candidates that can inhibit the function of the HIV-1 Vpu protein.
• To understand the binding requirements for effective inhibition at the Vpu protein's transmembrane domain.

Main Methods:

• Molecular docking simulations using the FlexX algorithm.
• Estimation of the free energy of binding for four candidate compounds.
• Analysis of hydrogen bonding interactions within the Vpu protein's transmembrane bundle.

Main Results:

• Four compounds were computationally docked to the pentameric transmembrane bundle of the HIV-1 Vpu protein.
• The binding free energy was estimated for each compound.
• Key interactions, specifically hydrogen bonds with neighboring or n+2 helices at the serine site, were identified as critical for binding.

Conclusions:

• Effective drug candidates targeting the HIV-1 Vpu protein must form specific hydrogen bonds within the transmembrane domain.
• The identified binding site, involving serines and adjacent helices, is crucial for Vpu protein inhibition.
• These findings provide a basis for designing novel HIV-1 therapeutics targeting the Vpu protein.